EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:135775 |
| ChEBI Name | mosapramine |
| Stars | |
| Definition | A racemate comprising equimolar amounts of (R)- and (S)-mosapramine. It is a second-generation antipsychotic used for the treatment of schizophrenia. |
| Last Modified | 14 January 2021 |
| Formula | C28H35ClN4O |
| Net Charge | 0 |
| Average Mass | 479.070 |
| Monoisotopic Mass | 478.24994 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. |
| Applications: | second generation antipsychotic Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements. dopaminergic antagonist A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| mosapramine (CHEBI:135775) has part (R)-mosapramine (CHEBI:166971) |
| mosapramine (CHEBI:135775) has part (S)-mosapramine (CHEBI:166970) |
| mosapramine (CHEBI:135775) has role dopaminergic antagonist (CHEBI:48561) |
| mosapramine (CHEBI:135775) has role second generation antipsychotic (CHEBI:65191) |
| mosapramine (CHEBI:135775) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| rac-1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one |
| INNs | Source |
|---|---|
| mosapramine | WHO MedNet |
| mosapramine | WHO MedNet |
| mosapraminum | WHO MedNet |
| mosapramina | WHO MedNet |
| Synonyms | Source |
|---|---|
| Y-516 | DrugCentral |
| clospipramine | DrugCentral |
| rac-mosapramine | ChEBI |
| racemic mosapramine | ChEBI |
| (RS)-mosapramine | ChEBI |
| (±)-mosapramine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 1847 | DrugCentral |
| DB13676 | DrugBank |
| D08235 | KEGG DRUG |
| Mosapramine | Wikipedia |
| 4107 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:89419-40-9 | ChemIDplus |
| Citations |
|---|